Molecular BiologyJournal of Biological ChemistryPeer-reviewed
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease.
Yuhong Du, William J. Bradshaw, Tina M. Leisner…·Vittorio L. Katis
This study identifies MSN and CD44 as potential therapeutic targets for Alzheimer's disease by developing inhibitors of their interaction through structural and chemical screening.
18 citations